Sweetch Funding: How Much Did They Raise & Key Investors

How Much Did Sweetch Raise?
Funding & Key Investors

Sweetch, a pioneer in the digital therapeutics sector, has successfully secured a major strategic investment, bringing its total capital raised to $20M. This latest financing round, which saw a recent funding amount of $20M, underscores the growing market confidence in the company's proprietary behavioral science platform. By integrating artificial intelligence with emotional intelligence, Sweetch is positioning itself as a critical infrastructure provider for the healthcare industry, facilitating long-term patient engagement at scale.

The capital infusion marks a significant milestone in the company's growth trajectory, enabling the Tel Aviv-based firm to accelerate its mission of transforming chronic condition management. As the healthcare landscape shifts toward value-based care, Sweetch's ability to deliver hyper-personalized, context-aware interventions has attracted substantial interest from institutional backers and strategic partners alike.

What is Sweetch?

Sweetch

Software

Healthcare Software

Mobile App Development

Founded in 2013, Sweetch operates at the intersection of behavioral science and digital health. The company provides a clinically validated platform designed to assist pharmaceutical firms, device manufacturers, and healthcare providers in maintaining continuous, meaningful relationships with patients. Unlike traditional health applications, Sweetch utilizes advanced algorithms to deliver recommendations that are optimized for the right time, tone, and real-world context of the individual. This approach effectively bridges the gap between clinical intent and patient adherence, addressing the complex challenges associated with managing chronic conditions in a modern, digital-first environment.

How much funding has Sweetch raised?

Sweetch has raised a total of $20M across 1 funding round:

2021

Series A

$20M

Series A (2021): $20M with participation from FinTLV Ventures, Kortex Ventures, Noaber, Entree Capital, and Tal-Cap

Key Investors in Sweetch

Entree Capital

Entree Capital backs founders building ambitious technology and product businesses, partnering with teams from the earliest stages through scale up.

Tal-Cap

Tal Cap, Inc. focuses on acquiring viable businesses and providing strategic support to facilitate long-term growth and operational success.

FinTLV Ventures

A venture capital firm specializing in the insurtech and fintech sectors, providing strategic backing to innovative technology companies.

What's next for Sweetch?

With this major enterprise-level funding, Sweetch is poised to scale its operations and expand its footprint within the global digital therapeutics market. The strategic roadmap likely involves deepening its integration with existing healthcare ecosystems and enhancing its AI-driven recommendation engine to support a broader range of chronic conditions. By leveraging its recent capital, the company is well-positioned to solidify its market leadership, drive clinical outcomes, and establish new standards for patient-centric digital health solutions. The focus remains on scaling its platform to meet the increasing demand for personalized, data-driven health interventions that improve patient quality of life while reducing the overall burden on healthcare systems.

See full Sweetch company page

See More Financial Insights